To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.
Collaboration

What’s With Those Socks?

Leigh Anne Naas Headshot
Leigh Anne Naas
November 19th, 20154 minute read
What's With Those Socks Feature Image

As we monitored our Twitter feed here at Lilly HQ, we noticed something interesting: people kept tweeting about pink socks. Everyone from clinical researchers to startup owners were tweeting—usually from health care conferences—using the hashtag #PinkSocks and often including pictures of themselves wearing bright pink socks with mustaches. So we decided to get to the bottom of it.

After a bit of Twitter sleuthing we found the original source of the pink socks: Nick Adkins. Nick is currently the COO and CoFounder of med-tech startup, ReelDX. We were lucky enough to have a chance to speak with Nick about what the pink socks are and how this phenomenon started.

It started at Burning Man

The pink socks story has its roots in one man’s personal transformation. Back in 2010, Nick was COO of a different health care company, seeking answers to business in particular and life in general. As part of his personal quest, he followed the advice of a chance encounter in New Orleans ten years earlier to attend the Burning Man festival. He spent a week in the Nevada desert practicing the 10 principles—including communal effort, civic responsibility and gifting—and he returned a changed man.

Nick sold his company, packed his bags, and moved from Nashville, Tennessee, to Portland, Oregon. Through new-found connections in his adopted city and motivated by a desire to support local entrepreneurs, he began wearing kilts (his friend owns a kilt company in Portland) and fun socks (another friend owns a sock company).

One of those new pairs of socks was pink. With black handlebar mustaches.

A movement is born

As Nick attended health care conferences around the country to pitch his new product—a HIPAA-compliant secure video API called medvid.io—he was recognized for his awesome socks. Hands-down, the most popular pair were the pink ones. As he prepared to attend the HIMSS conference in Chicago in April this year, Nick decided to bring a bunch of pink socks with him to give away.

In true Burning Man style, the gift was pure: there were no expectations for reciprocation, and the meaning of the gift was left to the receiver to attribute. Each time he gave a pair of socks, he said, “I’ve got this awesome friend in Portland who owns a sock company. She’s awesome. I’m awesome. You’re awesome. Wear these socks and I promise they’ll make people smile every time you wear them.”

pinksocks2

As he walked into the 42,000 person conference, one of the first people he ran into was Eric Topol. Nick gave a pair of socks to Dr. Topol and tweeted their picture together. It went viral on social media. Suddenly, the socks were a “thing.” Nick and his colleagues now share the gift at every conference they attend. To date, he estimates that they’ve given out over 1,000 pairs of pink socks.

Asked about the meaning of the pink socks, Nick is candid: “They really didn’t mean anything, they’re just fun and they make people smile. People can have them mean whatever they like.”

But somewhere along the way, they’ve found a deeper meaning, attributed by Gregg Masters: “Everybody who’s wearing the pink socks is disrupting health care from the ground up.”

It will take all of us

“To achieve the promise of new approaches to health care,” Nick says, “it will take all of us—technology companies, pharmaceutical companies, hospitals, research centers, patients, providers—all working together towards a common goal.” This vision encompasses another of Nick’s favorite hashtags, #EINpower, which began with one of Twitter’s most prolific physicians, Bernadette Keefe, MD. She saw ReelDX’s mascot Ein, the corgi/data dog on ReelDX’s site, and tweeted the hashtag to emphasize the importance of us all being in this together. “Ein” is German for “one,” and the hashtag connotes the power of one.

But in the quirky, unpredictable world of social media, it is #PinkSocks rather than #EINpower that has caught on and is taking the health care disruption circuit by storm.

pinksocks1

To follow the movement and learn more about Nick’s work at ReelDX, check out #PinkSocks, #EINpower, or Nick’s Twitter feed.

*Full disclosure: the writer of this blog post is the proud owner of a pair of pink socks!

Blog post originally appeared on LillyPad.

Tags: Advocacy,

Recent Articles

Lab Samples and Clinical Research 101 Feature Image

Lab Samples and Clinical Research: 101

Leigh Anne Naas Headshot
Leigh Anne Naas
April 19th, 20194 minute read

Lab samples provide some of the most important knowledge we gain in clinical research. Learn when, where and why samples are collected during a trial.

Patient interviewee and Lilly interviewer

The Balance of Clinical Trial Participation

Leigh Anne Naas Headshot
Leigh Anne Naas
March 28th, 20193 minute read

Melissa, a past Lilly clinical trial participant, sat down with us to share a bit about her research experience. Watch this video to hear Melissa's story in her own words.

Wale standing in front of wall with music notes

A Clinical Research Symphony

Leigh Anne Naas Headshot
Leigh Anne Naas
February 25th, 20194 minute read

For Wale, a physician who helps guide the strategy, design and procedural decisions for Lilly's clinical trials, clinical research is like an orchestra. Learn why.

BasketandUmbrellaStudies FeatureImage 6Feb2019-01

Clinical Trial Design: Basket and Umbrella Studies

Leigh Anne Naas Headshot
Leigh Anne Naas
February 8th, 20194 minute read

Newer approaches to clinical trial design have emerged, thanks, in part, to the power of precision medicine.

World Cancer Day 2019 Feature Image

Pediatric Cancer Experiences: Then and Now

Leigh Anne Naas Headshot
Leigh Anne Naas
February 4th, 20194 minute read

Meet two people who tackled cancer head-on as children and now are dedicated to contributing to the development of new cancer medicines.